Ofatumumab As Part Of Reduced Intensity Conditioning In High Risk B-Cell Lymphoma Patients: Results From A Prospective Multicenter Phase-Ii Trial

BONE MARROW TRANSPLANTATION(2020)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要